603367 辰欣药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.0906.9398.7169.4286.738
总资产报酬率 ROA (%)1.7145.5616.8357.3675.311
投入资产回报率 ROIC (%)1.9946.5888.2228.8786.399

边际利润分析
销售毛利率 (%)57.97551.88756.57358.78855.995
营业利润率 (%)16.96314.51214.36713.2808.966
息税前利润/营业总收入 (%)16.38013.53013.64512.5988.320
净利润/营业总收入 (%)15.53612.35612.93311.7758.664

收益指标分析
经营活动净收益/利润总额(%)111.16971.64886.51199.96895.161
价值变动净收益/利润总额(%)10.45332.88012.6505.6634.249
营业外收支净额/利润总额(%)-0.273-0.7430.6470.5500.439

偿债能力分析
流动比率 (X)4.6524.2573.3333.6283.701
速动比率 (X)4.1233.7482.7883.1113.249
资产负债率 (%)16.89117.99020.74321.41521.412
带息债务/全部投入资本 (%)2.9972.7764.4584.5674.527
股东权益/带息债务 (%)3,183.8323,437.7372,118.0932,063.5452,078.695
股东权益/负债合计 (%)488.877452.981379.711364.479365.406
利息保障倍数 (X)-30.488-15.472-16.725-16.697-12.136

营运能力分析
应收账款周转天数 (天)65.90061.21861.93258.75854.201
存货周转天数 (天)156.141155.756158.092126.130118.211